Patents matching “treatment”

US 7094413

Combined therapy for treatment of HIV infection

The Regents of the University of California · Granted Aug 22, 2006 · Expires Aug 17, 2026

US 7074893

Methods and compositions for the treatment of diseases associated with signal transduction aberrations

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 11, 2006 · Expires Jul 6, 2026

US 7067109

Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

US 7067254

Diagnosis and treatment of inflammation and hyperactive immune conditions

The Board of Regents of the University of Texas System · Granted Jun 27, 2006 · Expires Jun 22, 2026

US 7052832

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted May 30, 2006 · Expires May 25, 2026

US 7049066

Diagnosis and treatment of myocardial failure

The Regents of the University of Colorado · Granted May 23, 2006 · Expires May 18, 2026

US 7045510

Methods for prevention and treatment of mastitis

The United States of America, as represented by the Secretary of Agriculture · Granted May 16, 2006 · Expires May 11, 2026

AU 2002212120

Lipase inhibitors for the treatment of dyspepsia

CHEPLAPHARM ARZNEIMITTEL GMBH [DE] · Granted May 11, 2006 · Expires May 6, 2026

US 7033582

Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 25, 2006 · Expires Apr 20, 2026

US 7033771

Use of insulin response modulators in the treatment of diabetes and insulin resistance

Takeda Pharmaceutical Company Limited · Granted Apr 25, 2006 · Expires Apr 20, 2026

US 7018986

Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption

Immudyne, Inc. · Granted Mar 28, 2006 · Expires Mar 23, 2026

US 7014847

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Mar 21, 2006 · Expires Mar 16, 2026

US 7012064

Cyclosporins for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Mar 14, 2006 · Expires Mar 9, 2026

US 7012065

Cyclosporins for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Mar 14, 2006 · Expires Mar 9, 2026

US 7001884

Eglin c based drugs for treatment of disease

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 21, 2006 · Expires Feb 16, 2026

US 6998117

Cancer treatment with retroviral vectors comprising wild-type p53

The Board of Regents of the University of Texas System · Granted Feb 14, 2006 · Expires Feb 9, 2026

US 6998413

Treatment of neoplasms with yujungamycins

ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 14, 2006 · Expires Feb 9, 2026

US 6995188

S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

The Board of Regents of the University of Texas System · Granted Feb 7, 2006 · Expires Feb 2, 2026

US 6992096

1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

PTC THERAPEUTICS, INC. · Granted Jan 31, 2006 · Expires Jan 26, 2026

US 6987166

Compositions and methods for the treatment of sepsis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jan 17, 2006 · Expires Jan 12, 2026

US 6984389

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

University of Connecticut Health Center · Granted Jan 10, 2006 · Expires Jan 5, 2026

US 6979671

Cyclosporins for the treatment of immune disorders

Enanta Pharmaceuticals, Inc. · Granted Dec 27, 2005 · Expires Dec 22, 2025

US 6974568

Treatment for cough

The Regents of the University of California · Granted Dec 13, 2005 · Expires Dec 8, 2025

US 6972124

Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme

BIOMARIN PHARMACEUTICAL INC. · Granted Dec 6, 2005 · Expires Dec 1, 2025